Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Regenerative Medicine Aided by Nanotechnology Strategies

By BiotechDaily International staff writers
Posted on 19 Nov 2013
Nanotechnology may provide new approaches for regenerative medicine, including better ways to restore or enhance damaged tissues, according to a review article by Taiwanese researchers.

Published October 2013 in the journal Science and Technology of Advanced Materials, the study reported on the current state of knowledge on nanotechnology with a focus on stem cell biology applications. Stem cells are an important potential source for repairing injured human tissues. Researchers have found that the adhesion, growth, and differentiation of stem cells are most probably controlled by their surrounding microenvironment, which contains both physical and chemical signals. These signals include the “nanotopography” of the complicated extracellular matrix that comprises a network for human tissues.

Dr. Yang-Kao Wang and colleagues from Taipei Medical University (Taipei City, Taiwan) described in their article studies showing how this nanotopography (which includes nanosized pores, ridges, and grooves) plays critical roles in the behavior and fate of stem cells. The authors also discussed the application of nanoparticles to stem cell isolation, tracking and imaging; how to convert nanotechnology tools from two to three dimensions; and the potential limitations of using nanomaterials in stem cell biology.

The authors concluded that “understanding [the] interactions of nanomaterials with stem cells may provide knowledge applicable to [the development of improved] cell-scaffold combinations in tissue engineering and regenerative medicine.”

Related Links:

Taipei Medical University



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission (EC) has approved a new therapeutic option for the most difficult to treat form of ovarian cancer. Ovarian cancer causes more deaths... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research. Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.